Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea in adults with obesity, the drugmaker said in a release Wednesday.
Related Posts
First woman, Latina CEO leads Elmhurst Hospital in Queens
- blkalertshealth
- March 26, 2024
- 0
Helen Arteaga Landaverde is the first woman and fi
Most Cancer Drugs Granted Accelerated FDA Approval May Not Work
- blkalertshealth
- April 9, 2024
- 0
The U.S.
What to Do About Your Bunions
- blkalertshealth
- April 25, 2024
- 0
April Leonard likes to blame her bunions on